IMUTEX Ltd

Imutex ltd email format

Verified email-pattern data for Imutex Ltd is currently limited. You can still use the company insights and contact sections below.
Imutex Limited, formed in 2016, is a joint venture between SEEK Group and hVIVO, part of Open Orphan plc, to accelerate the development of a Broad-Spectrum ‘Universal’ Influenza Vaccine, FLU-v, and a Mosquito-Borne Diseases Vaccine, AGS-v. The development of the FLU-v Universal Flu Vaccine and the AGS-v Mosquito-Borne Diseases vaccines are key public health priorities identified by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) in the United States. Imutex is collaborating with the National Institute of Allergy and Infectious Diseases (NIAID) to accelerate development of both vaccines.

Company Details

Employees
2
Founded
-
Phone
+44 207 036 8550
Industry
Pharmaceutical Manufacturing
Website
imutex.com
Looking for a particular IMUTEX Ltd employee's phone or email?

Imutex Ltd Questions

Explore related pages

Related company profiles:

Top IMUTEX Ltd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant